A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications (Q47182118)

11 January 2018

title

A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications (English)

1 reference

11 January 2018

0 references

1

1 reference

11 January 2018

author name string

Shannon L Janoff

series ordinal

2

1 reference

11 January 2018

Bobbi Jo H Yarborough

series ordinal

3

1 reference

11 January 2018

Micah T Yarborough

series ordinal

4

1 reference

11 January 2018

language of work or name

English

0 references

publication date

25 February 2014

1 reference

11 January 2018

Community Mental Health Journal

published in

1 reference

11 January 2018

volume

50

1 reference

11 January 2018

page(s)

974-980

1 reference

11 January 2018

issue

8

1 reference

11 January 2018

https://scigraph.springernature.com/pub.10.1007/s10597-014-9716-9

exact match

0 references

cites work

Obesity among those with mental disorders: a National Institute of Mental Health meeting report.

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

The effect of the PREMIER interventions on insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Clinically significant improved fitness and weight loss among overweight persons with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Maintenance of physical activity following an individualized motivationally tailored intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Is obesity stigmatizing? Body weight, perceived discrimination, and psychological well-being in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

A behavioral weight-loss intervention in persons with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

PREMIER--a trial of lifestyle interventions for blood pressure control: intervention design and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Obesity and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

The development of scales to measure social support for diet and exercise behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Psychiatric medication-induced obesity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Body mass index and quality of life in community-dwelling patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Health and economic burden of the projected obesity trends in the USA and the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Obesity as a risk factor for antipsychotic noncompliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10597-014-9716-9

Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial

21 January 2018

1 reference

12 December 2020

Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial

1 reference

12 December 2020

Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature

1 reference

12 December 2020

Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Weight gain associated with antipsychotic drugs.

1 reference

12 December 2020

The Wisconsin Quality of Life Index: a multidimensional model for measuring quality of life.

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Antipsychotic-induced weight gain: a review of the literature

1 reference

12 December 2020

Metabolic disturbance in first-episode schizophrenia.

1 reference

12 December 2020

Stages and processes of self-change of smoking: toward an integrative model of change

1 reference

12 December 2020

Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.

1 reference

12 December 2020

10.1007/S10597-014-9716-9

Identifiers

DOI

1 reference

11 January 2018

Dimensions Publication ID

1013920266

0 references

Fatcat ID

release_onnj6lqk3jbbdkcvr4zjpe72nq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/onnj6lqk3jbbdkcvr4zjpe72nq

24 November 2022

mapped directly with Wikidata item

PubMed ID

24566560

1 reference

11 January 2018